{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:33:27Z","timestamp":1789958007119,"version":"4.0.1"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004690","name":"Minist\u00e8re de la Sant\u00e9","doi-asserted-by":"publisher","award":["AOM17464"],"award-info":[{"award-number":["AOM17464"]}],"id":[{"id":"10.13039\/501100004690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","award":["n.a"],"award-info":[{"award-number":["n.a"]}],"id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess whether procalcitonin-guided decision making can safely reduce the duration of antibiotic treatment in neonatal late onset sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective multicentre, randomised open label trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>33 level 3 and level 2B neonatology departments in France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Newborn babies born after 24\u2009weeks\u2019 gestation, of postconceptional age 24-45 weeks and after 4 days of life, weighing more than 700\u2009g, with suspected or proven late onset sepsis, requiring antibiotics for more than 48 hours, and without meningitis, septic shock, and deep-seated infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomly assigned to procalcitonin-guided or usual care antibiotic treatment. In the procalcitonin-guided group, procalcitonin concentration was measured at randomisation and then every two\u2009days. A non-binding recommendation to discontinue antibiotics was given if the procalcitonin concentration was 0.5\u2009\u00b5g\/L or lower. In the usual care group, treatment was provided according to local protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>The primary outcome was the duration of antibiotic treatment (under the superiority hypothesis). The key secondary outcome was non-inferiority for mortality (margin 3%) at day 28 after randomisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between February 2019 and February 2023, 248 newborns were randomised to the procalcitonin-guided group and 256 to the usual care group. In the intention-to-treat analysis, the median duration of antibiotic treatment was eight\u2009days (interquartile range (IQR) 5.0-12.0) in the procalcitonin-guided group versus 10 days (8.0-13.0) in the usual care group (absolute difference between groups \u22122.0 (IQR \u22123.8 to \u22121.0), P&lt;0.001). At day 28, the proportion of death was six of 248 newborns (2.4%) in the procalcitonin-guided group versus 10 of 256 (3.9%) in the usual care group (absolute difference between groups \u22121.5% (95% confidence interval (CI) \u22125.0 to 1.8). The proportion of recurrence was seven of 248 (2.8%) newborns in the procalcitonin-guided group versus 10 (3.9%) of 256 in the usual care group (absolute difference between groups \u22121.1% (95% CI \u22124.6 to 2.3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study population, the use of procalcitonin significantly reduced the duration of antibiotic treatment in neonatal late onset sepsis, without increasing mortality or serious adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03730636\">NCT03730636<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2026-002602","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T17:00:16Z","timestamp":1779037216000},"page":"e002602","source":"Crossref","is-referenced-by-count":1,"title":["Procalcitonin-guided decision and antibiotic treatment duration in late onset sepsis of newborns: multicentre, randomised controlled trial (ProABIS)"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-6846","authenticated-orcid":false,"given":"Delphine","family":"Mitanchez","sequence":"first","affiliation":[{"name":"Department of Neonatology, Tours University Hospital, Tours, France"},{"name":"INSERM UMRS 938, Centre de Recherche Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7305-9118","authenticated-orcid":false,"given":"Romane","family":"Lacoste-Badie","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-8244","authenticated-orcid":false,"given":"Cyril","family":"Flamant","sequence":"additional","affiliation":[{"name":"Neonatology, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-7085","authenticated-orcid":false,"given":"Alain","family":"Beuch\u00e9e","sequence":"additional","affiliation":[{"name":"Neonatology, Rennes University Hospital, Rennes, France"},{"name":"University of Rennes, Inserm, LTSI-UMR 1099, LTSI, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-4863","authenticated-orcid":false,"given":"Pierre","family":"Tourneux","sequence":"additional","affiliation":[{"name":"Neonatal intensive care, Amiens-Picardie University Hospital, Amiens, France"},{"name":"UMR-I 01, Universit\u00e9 de Picardie Jules Verne, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9662-738X","authenticated-orcid":false,"given":"Mostafa","family":"Mokhtari","sequence":"additional","affiliation":[{"name":"Neonatology, Universit\u00e9 Paris-Saclay Facult\u00e9 de M\u00e9decine, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-0429","authenticated-orcid":false,"given":"Pierre-Henri","family":"Jarreau","sequence":"additional","affiliation":[{"name":"Neonatalogy, Paris Cit\u00e9 University APHP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-8820","authenticated-orcid":false,"given":"Sophie","family":"Tuffet","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-7092","authenticated-orcid":false,"given":"Laurence","family":"Berard","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-185X","authenticated-orcid":false,"given":"Alexandra","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-2344","authenticated-orcid":false,"given":"Christele","family":"Gras-Le Guen","sequence":"additional","affiliation":[{"name":"Pediatric Medical Clinic, Nantes University, Nantes, France"},{"name":"Clinical investigation Center Women Children 1413 INSERM-CHU, University Hospital Centre Nantes Division 5 Women Children Adolescents, Nantes, France"},{"name":"Centre for Research in Epidemiology and Statistics, Inserm, INRAE, Centre for Research in Epidemiology and Statistics, Universit\u00e9 Paris Cit\u00e9 and Universit\u00e9 Sorbonne, Paris nord, F-75004, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"key":"2026061106050919000_5.1.e002602.1","doi-asserted-by":"crossref","first-page":"1139832","DOI":"10.3389\/fpubh.2023.1139832","article-title":"Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990\u20132019","volume":"11","author":"Li","year":"2023","journal-title":"Front Public Health"},{"key":"2026061106050919000_5.1.e002602.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.05.048"},{"key":"2026061106050919000_5.1.e002602.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10244"},{"key":"2026061106050919000_5.1.e002602.4","unstructured":"WHO . 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"2026061106050919000_5.1.e002602.5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOP.0000000000000338","article-title":"Adverse consequences of neonatal antibiotic exposure","volume":"28","author":"Cotten","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"2026061106050919000_5.1.e002602.6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamapediatrics.2016.2132","article-title":"Association Between Antibiotic Use and Neonatal Mortality and Morbidities in Very Low-Birth-Weight Infants Without Culture-Proven Sepsis or Necrotizing Enterocolitis","volume":"170","author":"Ting","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2026061106050919000_5.1.e002602.7","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.129"},{"key":"2026061106050919000_5.1.e002602.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0896"},{"key":"2026061106050919000_5.1.e002602.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.01.010"},{"key":"2026061106050919000_5.1.e002602.10","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-315412"},{"key":"2026061106050919000_5.1.e002602.11","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/712150","article-title":"Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis","volume":"2011","author":"Sivanandan","year":"2011","journal-title":"Int J Pediatr"},{"key":"2026061106050919000_5.1.e002602.12","unstructured":"NICE . Neonatal infection: antibiotics for prevention and treatment. 2024. Available: www.nice.org.uk\/guidance\/ng195"},{"key":"2026061106050919000_5.1.e002602.13","unstructured":"WHO . WHO recommendations for management of serious bacterial infections in infants aged 0\u201359 days. 2024. Available: https:\/\/iris.who.int\/handle\/10665\/379653"},{"key":"2026061106050919000_5.1.e002602.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-023-04677-2","article-title":"Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis","volume":"27","author":"Papp","year":"2023","journal-title":"Crit Care"},{"key":"2026061106050919000_5.1.e002602.15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255"},{"key":"2026061106050919000_5.1.e002602.16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","article-title":"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)","volume":"390","author":"Stocker","year":"2017","journal-title":"The Lancet"},{"key":"2026061106050919000_5.1.e002602.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31002-4"},{"key":"2026061106050919000_5.1.e002602.18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000539245","article-title":"Late-Onset Sepsis among Extremely Preterm Infants of 24\u201328 Weeks Gestation: An International Comparison in 10 High-Income Countries","volume":"121","author":"Klinger","year":"2024","journal-title":"Neonatology"},{"key":"2026061106050919000_5.1.e002602.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30205-5"},{"key":"2026061106050919000_5.1.e002602.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059230","article-title":"Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997\u20132020)","volume":"12","author":"Jacques","year":"2022","journal-title":"BMJ Open"},{"key":"2026061106050919000_5.1.e002602.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1"},{"key":"2026061106050919000_5.1.e002602.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00053-0"},{"key":"2026061106050919000_5.1.e002602.23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0044","article-title":"Ending the Culture of Culture-Negative Sepsis in the Neonatal ICU","volume":"140","author":"Cantey","year":"2017","journal-title":"Pediatrics"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2026-002602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:05:21Z","timestamp":1781183121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2026-002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,17]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjmed-2026-002602"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2026-002602","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}